(PharmaNewsWire.Com, July 12, 2017 ) The pre-filled syringe was introduced in the market in around 1975 as a part of the injectable drug delivery devices. It gained popularity and became the preferred packaging and delivery device for injectable drugs after the successful introduction of heparin pre-filled syringe by Sanofi and Rhone-Poulenc Rorer into the European market in the early 1980s. Approximately three to four billion pre-filled syringes are being produced annually and are expected to increase by 8%-10% every year. There is a deep interest in the healthcare industry for pre-filled syringe because of its convenience and acceptance by patients, indicating the strong growth potential of the pre-filled syringes market.
Publisher's analysts forecast the global pre-filled syringes market to grow at a CAGR of 10.07 % during the period 2017-2021. For more information about this report: http://www.reportsweb.com/global-pre-filled-syringes-market-2017-2021 . Covered in this report The report covers the present scenario and the growth prospects of the global pre-filled syringes market for 2017-2021. To calculate the market size, the report considers the sales/value of pre-filled syringes.
The market is divided into the following segments based on geography: -Americas -APAC -EMEA
Publisher's report, Global Pre-filled Syringes Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
